(Q41084946)

English

Endothelial dysfunction in preeclampsia. Part II: Reducing the adverse consequences of endothelial cell dysfunction in preeclampsia; therapeutic perspectives

scientific article published on January 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

1 reference

Europe PubMed Central

Endothelial dysfunction in preeclampsia. Part II: Reducing the adverse consequences of endothelial cell dysfunction in preeclampsia; therapeutic perspectives (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

0 references

0 references

author name string

Dekker GA

1

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

van Geijn HP

2

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 1996

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Journal of Perinatal Medicine

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

119-139

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Interactions between organic nitrates and thiol groups

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

Platelets and thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

Evidence against the hypothesis that prostaglandins are the vasodepressor agents of pregnancy. Serial studies in chronically instrumented, conscious rats

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

Cardiovascular alterations in severe pregnancy-induced hypertension: effects of intravenous nitroglycerin coupled with blood volume expansion

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

Endothelial dysfunction in preeclampsia. Part I: Primary prevention. Therapeutic perspectives

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

Early detection of preeclampsia

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

Thromboxane A2 synthesis in pregnancy-induced hypertension

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

A study of angiotensin II pressor response throughout primigravid pregnancy

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

The emerging concept of vascular remodeling

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

Reduction in human fetal umbilical-placental vascular resistance by glyceryl trinitrate.

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

Plasma endothelin-1 levels in patients with pregnancy-induced hypertension

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

Heparin inhibits endothelin-1 production in cultured rat mesangial cells

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

Nitric oxide: an endogenous modulator of leukocyte adhesion

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

Do we need endothelin antagonists?

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

The effect of nifedipine therapy on fetal and placental Doppler waveforms in preeclampsia remote from term.

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

Cyclic guanosine monophosphate as a mediator of vasodilation

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

Proposed roles for growth factors in mediating smooth muscle proliferation in vascular pathologies

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

A possible preventive effect of low-dose fish oil on early delivery and pre-eclampsia: indications from a 50-year-old controlled trial

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

Does fish consumption during pregnancy increase fetal growth? A study of the size of the newborn, placental weight and gestational age in relation to fish consumption during pregnancy

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

Hyperhomocysteinaemia and recurrent spontaneous abortion or abruptio placentae

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

Serotonergic antagonists and vascular disease

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

The role of serotonin in the preeclampsia-eclampsia syndrome

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

Approaches to the development of selective inhibitors of vascular smooth muscle cell proliferation.

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

Cardiovascular Effects of n-3 Fatty Acids

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.119

21 January 2018

Identifiers

10.1515/JPME.1996.24.2.119

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41084946&oldid=2093407839"